D. Pascut

发表

Silencing efficacy prediction: a retrospective study on target mRNA features

G. Bedogni, C. Tiribelli, D. Pascut, 2015, Bioscience reports.

Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader–Willi Syndrome and Non-Syndromic Obesity

C. Tiribelli, A. Sartorio, G. Grugni, 2020, Journal of clinical medicine.

Antiphospholipid antibodies and lipoprotein(a) in obese children

D. Pascut, S. Parco, T. Princi, 2009, Acta paediatrica.

Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals

C. Tiribelli, D. Pascut, L. K. Cabral, 2022, Cancers.

HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development

C. Tiribelli, D. Pascut, Muhammad Yogi Pratama, 2021, Cancers.

Recent Hints on the Dual Role of Discs Large MAGUK Scaffold Protein 5 in Cancers and in Hepatocellular Carcinoma.

C. Tiribelli, D. Pascut, Chiara Andolfi, 2022, Frontiers in bioscience.

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs

C. Tiribelli, D. Pascut, Caecilia H C Sukowati, 2015, Expert review of gastroenterology & hepatology.

A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients

H. Krmac, C. Tiribelli, R. Calligaris, 2019, Scientific Reports.

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma

C. Tiribelli, D. Pascut, L. K. Cabral, 2021, Biomedicines.

The role of microRNA in the resistance to treatment of hepatocellular carcinoma.

C. Tiribelli, M. Massi, D. Pascut, 2019, Annals of translational medicine.

Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals

G. Bedogni, G. Basso, C. Tiribelli, 2019, Cancers.

The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical Implications

C. Tiribelli, D. Pascut, Muhammad Yogi Pratama, 2020, Cancers.

A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients

H. Krmac, C. Tiribelli, R. Calligaris, 2019, Scientific Reports.

A. Bozzato, M. Cova, C. Tiribelli, 2022, Diagnostics.

The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer

C. Tiribelli, D. Pascut, Muhammad Yogi Pratama, 2021, Cancers.

Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma

C. Tiribelli, D. Pascut, L. Crocè, 2020, Cancers.

Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma

C. Tiribelli, D. Pascut, L. Chemello, 2020, Scientific Reports.

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

C. Tiribelli, M. Massi, D. Pascut, 2017, Oncotarget.

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma

C. Tiribelli, N. Rosso, P. Francalanci, 2012, BMC Gastroenterology.

MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma

C. Tiribelli, D. Pascut, L. Crocè, 2022, Technology in cancer research & treatment.

Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients

C. Tiribelli, V. Sergo, A. Bonifacio, 2020, Analytical and Bioanalytical Chemistry.

Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia

C. Tiribelli, F. Zanconati, S. Gazzin, 2023, Biology.

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance

C. Tiribelli, D. Pascut, Muhammad Yogi Pratama, 2020, Hepatic oncology.

Differences in circulating microRNA signature in Prader–Willi syndrome and non-syndromic obesity

G. Basso, P. Giraudi, C. Tiribelli, 2018, Endocrine connections.

Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients

C. Tiribelli, D. Pascut, M. Giuffré, 2020, Scientific Reports.

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma

G. Tell, C. Tiribelli, L. Mascaretti, 2019, Oncotarget.

Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma

C. Tiribelli, D. Pascut, L. Chemello, 2020, Scientific Reports.

Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma

E. Dalla, G. Tell, V. De Sanctis, 2023, Journal of clinical and translational hepatology.

Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care.

D. Pascut, Inah Marie C Aquino, 2023, Annals of hepatology.

The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer

D. Pascut, L. Grisetti, Clarissa J C Garcia, 2024, Cell proliferation.

Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome

P. Giraudi, C. Banfi, S. Ghilardi, 2023, Frontiers in endocrinology.